Brief Report: Interleukin‐17 Blockade With Secukinumab in Peripheral Spondyloarthritis Impacts Synovial Immunopathology Without Compromising Systemic Immune Responses - Concepedia

Concepedia

Publication | Closed Access

Brief Report: Interleukin‐17 Blockade With Secukinumab in Peripheral Spondyloarthritis Impacts Synovial Immunopathology Without Compromising Systemic Immune Responses

51

Citations

22

References

2018

Year

Leonieke van Mens, M. G. H. Van de Sande, Silvia Menegatti, Sijia Chen, Iris C. Blijdorp, Henriëtte M. de Jong, Inka A. Fluri, Talia E. Latuhihin, Arno W. R. van Kuijk, Lars Rogge,

Arthritis & Rheumatology

Abstract

This mechanism-of-action study in peripheral SpA indicates that clinical improvement with secukinumab treatment is paralleled by immunomodulation of inflamed target tissues without compromising systemic immune responses.

References

	Year	Citations

Page 1